Immunic Inc is a biopharmaceutical company focused on developing innovative treatments for autoimmune and inflammatory diseases. The company is dedicated to advancing therapies that can address unmet medical needs, utilizing a proprietary drug development platform. Immunic is particularly engaged in researching and formulating oral medications that target specific pathways in immune response, with the aim of improving the quality of life for patients suffering from conditions such as multiple sclerosis, ulcerative colitis, and other chronic inflammatory disorders. Through its commitment to scientific excellence and clinical research, Immunic seeks to establish itself as a leader in the field of immunology. Read More
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report.
Intrigued by the market activity one hour before the close of the markets on Wednesday? Uncover the key winners and losers of today's session in our insightful analysis.
The session on Wednesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top gainers and losers in today's pre-market session.
